Ivantis Hits 2 Major Milestones for its Minimally Invasive Glaucoma Surgery (MIGS)

08 January 2018

In October, Ivantis completed its pre-market approval for Hydrus Microstent, its Minimally Invasive Glaucoma Surgery procedure. Dave Van Meter, president and CEO of Ivantis, elaborates further on the importance of this milestone: “The submission of Ivantis’ PMA marks a significant milestone toward our goal of bringing the Hydrus Microstent to market in the United States […]

Continue Reading